Hemogenyx Pharmaceuticals Plc (HEMO) Ordinary Shares 1p
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Hemogenyx shares boosted by partner investment
2 October 2024 11:56
(Sharecast News) - Shares in Hemogenyx Pharmaceuticals jumped on Wednesday after the clinical-stage biopharmaceutical group announced another investment from Prevail Partners via a share subscription at a...
-
Hermogenyx shares soar on new partnership with Prevail Partners
18 September 2023 13:00
(Sharecast News) - Shares in biopharma group Hemogenyx surged on Monday after the company received a $0.83m investment from Prevail Partners as it continues to work on its planned clinical trial for...
Company announcements Announcements
-
IRB Approval for Phase I Clinical Trial
22 November 2024 07:00
Hemogenyx Pharmaceuticals
-
Institutional Investment
11 November 2024 07:00
Hemogenyx Pharmaceuticals
-
Schedule for Phase I Clinical Trial Opening
30 October 2024 07:00
Hemogenyx Pharmaceuticals
-
Strategic Investment from Prevail Partners, LLC
2 October 2024 11:19
Hemogenyx Pharmaceuticals
-
Half-year Report
27 September 2024 07:00
Hemogenyx Pharmaceuticals
-
CDX Development Update
2 September 2024 07:00
Hemogenyx Pharmaceuticals
-
Presentation at CBD S&T Conference
28 August 2024 07:00
Hemogenyx Pharmaceuticals
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.